Concepedia

Tomoyuki Wada

TW

Statistics

Publications

35

Citations

1.2K

H-Index

16

Active since

1977

Affiliations

Oita University(Current)

Tokyo University of Agriculture and Technology

Senju Pharmaceutical (Japan)

University of Chicago

University of Wisconsin–Madison

Tomoyuki Wada is an author at Oita University specializing in medicine, cardiology, and cardiothoracic surgery.

ORCID

Publications per year

1977–2024

35

Publications

35

Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 KATP channels

William A. Chutkow, Jielin Pu, Matthew T. Wheeler et al. · Journal of Clinical Investigation · 2002 · 234 citations · Full text

, , +17

Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 KATP channels

William A. Chutkow, Jielin Pu, Matthew T. Wheeler et al. · Journal of Clinical Investigation · 2002 · 187 citations

, , +17

Sodium‐dependent dynamic assembly of membrane complexes in sodium‐driven flagellar motors

Hajime Fukuoka, Tomoyuki Wada, Seiji Kojima et al. · Molecular Microbiology · 2008 · 132 citations · Full text

, , +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

, , +11

Empagliflozin Suppresses the Differentiation/Maturation of Human Epicardial Preadipocytes and Improves Paracrine Secretome Profile

M. Takano, Hidekazu Kondo, Taisuke Harada et al. · JACC Basic to Translational Science · 2023 · 39 citations · Full text

, , +17

1–5 of 35